If you would like to submit a blog post for consideration, please email email@example.com
[8 min watch] Easy-to-treat & difficult-to-treat basal cell carcinoma
In this skin cancer update video, Professor Giuseppe Argenziano and Dr Gabriella Brancaccio speak about the latest in basal cell carcinoma (BCC) treatment, including classifying BCCs as easy-to-treat and difficult-to-treat.
For further information on this topic, you may be interested to learn more about the HealthCert Professional Diploma program in Dermoscopy.
In the short video, Prof Argenziano and Dr Brancaccio look at recent research into the classifications of BCCs to identify a more practical and pragmatic way of treating them in primary care.
As BCCs are the most common skin cancers seen in primary care, it is important to use the correct and most effective approach for treatment in the first instance.
The two experts discuss how BCCs can be classified as either easy-to-treat or difficult-to-treat, and what each of these classifications entails.
See all this and much more in the full video below!
Watch the full video now:
More skin cancer updates from Professor Giuseppe Argenziano:
Prof Giuseppe Argenziano is Professor of Dermatology at the Department of Dermatology, Second University of Naples; Coordinator of the Skin Cancer Unit Research Hospital Santa Maria Nuova, Reggio Emilia, Italy; President of the International Dermoscopy Society; and member of the Editorial Board of the Journal of the American Academy of Dermatology.
Giuseppe has developed early diagnosis techniques for melanoma, authored over 300 scientific works and has been invited as speaker and/or chairman in more than 400 national and international conferences in the field of dermatology. He has authored more than 450 scientific articles and more than 30 books, and his publications have received a total of 6,200 citations with an h-index value of 40 (Scopus 02/2015). He is a key presenter of the HealthCert Professional Diploma of Dermoscopy program.
3 comments on “[8 min watch] Easy-to-treat & difficult-to-treat basal cell carcinoma”
I would like to participe and recibe all información about dermatology principaly oncodermatology
Thank you very mouch
Dra Carla Flores